Navigation Links
US BioDesign Relocation Expands Manufacturing Capabilities
Date:7/23/2013

QUAKERTOWN, Pa., July 23, 2013 /PRNewswire-iReach/ -- QUAKERTOWN, Pennsylvania (July 23, 2013) -- US BioDesign, LLC, a global leader in the production of biomedical textile structure components, today announced the relocation of its current manufacturing headquarters (in Perkasie, PA) to a business campus in Quakertown, PA.  At its new location, the company will develop and manufacture biomedical textile components for medical device manufacturers. The new facility encompasses clean room technology, state-of-the-art manufacturing equipment, increased capacity, and dedicated developmental support, in addition to expanded office space.

According to US BioDesign President and Founder Tom Molz, the company's relocation supports essential, short-term business goals and is key to advancing longer-term growth strategies.  "This is an exciting time for US BioDesign. With multiple developmental projects nearing commercialization, this is the right time for us to expand.  Our business is growing rapidly and we've got a lot of momentum moving forward. We're excited about the future," he said.

Comprised of surgical, cardiovascular, neurovascular, neurological, orthopedic, general medical and other devices, the global medical device industry has experienced significant growth over the last five years and is expected to continue. Neurology devices are predicted to post the fastest growth, expected to expand by 6.1% per year.

"Our decision to relocate was made in response to listening to our customers and our evaluation of where we see the industry moving, based on current and emerging industry trends. This move gives us the technological bandwidth and expanded manufacturing capabilities and capacity tha
'/>"/>

SOURCE US BioDesign
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Collegium Pharmaceutical Announces Relocation to Massachusetts
2. Kibow Biotech Marks Its Continued Growth with Relocation to Larger Facilities
3. BME Expands Surgeon Advisory Board
4. Senior Home Care Expands In-Home Telemonitoring to Serve Patients in The Villages, Fla. Area
5. Boehringer Ingelheim Renews and Expands License to NextBio Research Platform
6. Blue Sky BioServices Expands its Executive Team - Announces Appointment of Ted Marple as President and CEO
7. MicroConstants Expands Biomarker Testing and Analysis Services for Preclinical and Clinical Diagnostic Research
8. Grunenthal Expands Use of BioClinicas Next Generation Trident IWR/IVR for Global Trial
9. Amerivet Solutions Expands to Manufacture Complex Metal Designs
10. Life Technologies Expands Range of Stem Cell Reprogramming Solutions
11. QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ ... and Bloom Burton & Co. Ltd. ("Bloom Burton") today ... (the "Lock-Up") 2,353,130 common shares of the Company ("Common ... to the Lock-Up. Of the Common Shares released from ... upon release from the Lock-Up while the remainder will ...
(Date:2/27/2015)... Report Details   ... R&D progress, and predicted revenues ,Where is the market ... commercial prospects for this market and related technologies? Visiongain,s ... trends to 2025, discussing data, opportunities and prospects. ... regenerative medicine : cell-based therapies that aim to restore ...
(Date:2/27/2015)... 27, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" or ... announced financial results for its first quarter ended December ... ended December 31, 2014, revenue was $1,336,685. Operating expenses ... or $0.02 per share.  Covalon,s President ... very pleased with the significant progress we have made ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3
... DIEGO, Dec. 22, 2011 ViroPharma Incorporated (NASDAQ: ... exclusive option to acquire Meritage Pharma, Inc., a private company ... suspension (OBS) as a treatment for eosinophilic esophagitis (EoE), a ... has paid an initial $7.5 million, and has agreed to ...
... Therapeutics, Inc. (Nasdaq: OREX ) today announced the ... consisted of one share of common stock and a warrant ... to the public of $1.45 per share of common stock ... stock, which together comprised the purchase price of $15.94 per ...
Cached Medicine Technology:ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 2ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 3ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 4ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 5ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 6ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 7Orexigen® Therapeutics Completes Public Offering of Common Stock and Warrants to Purchase Common Stock 2
(Date:2/27/2015)... NY (PRWEB) February 27, 2015 In ... to the community by providing free dental care from ... has partnered with Dentistry from the Heart, and ... 11, 2015. The first 50 patients who are in ... they can’t afford, will have access to high­quality service ...
(Date:2/27/2015)... 2015 The federal court overseeing more ... use of the statin medication can increase a person’s ... new order pertaining discovery in the cases selected for ... comments. The Order, which was issued in the U.S. ... directs the parties to schedule certain witness depositions before ...
(Date:2/27/2015)... February 27, 2015 According to court ... Hospital on June 25, 2013 and underwent a procedure ... through her mouth. Because the duodenoscope allegedly had ... the antibiotic-resistant “superbug” carbapenem-resistant Enterobacteriaceae (CRE). , ... of Cook County on behalf of Ms. Pirolli alleging ...
(Date:2/27/2015)... FL (PRWEB) February 27, 2015 ... companies, devices and pharmaceuticals, Benedict Advertising & Marketing ... its newest client. The company’s patented NITROUSEAL® N20 ... pain-free, no-stress method of sedation. , Sedation Systems, ... patient comfort to a new level, though it ...
(Date:2/27/2015)... The Dawn Greene Hospice, a 10-bed facility located on ... the Upper East Side, was officially dedicated and blessed at ... Timothy Michael Cardinal Dolan. , Thomas J. Fahey, Jr., MD, ... member of the ArchCare Board of Trustees, presided over the ... director of MMW, and Christina McInerney, president and CEO of ...
Breaking Medicine News(10 mins):Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3
... Biology MeetingNEW ORLEANS, April 20 Research presented today ... lower cholesterol by 10 percent in one month. The ... Research, found that eating two 1 1/2 cup servings ... diet low in fat, lowered LDL or "bad" cholesterol ...
... longer, study suggests, , , MONDAY, April 20 (HealthDay News) -- Want ... how to manage your stress. , A new study found that ... lived to 100, and longevity is thought to run in families. ... traits that set the children of centenarians apart from other people ...
... Who better to provide healthy eating tips than ... Cardiovascular and Wellness Nutrition (SCAN) Dietetic Practice Group of ... the Great Tomato Tip-Off Contest!, a partnership effort between ... encouraged dietitians to send in their best tips for ...
... Scientists Discover Eating Cherries May Elevate Antioxidant Activity in ... and a half servings of tart cherries could significantly ... University of Michigan research reported at the ... study, healthy adults who ate a cup and a ...
... April 20 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: ... for the three-month period ended March 31, 2009. ... million compared to $1.173 million for the same ... for any quarter in the Company,s history and, ...
... Tenn., April 20 HCA Healthcare announces the following Webcast: What: ... 27, 2009 @ 10:00 EST , Where: ... the Internet -- Simply log on to the web , ... Contact: Mark Kimbrough, Investor Relations at HCA Healthcare, , ...
Cached Medicine News:Health News:Cheerios(R) Can Help Reduce Cholesterol 10 Percent in One Month 2Health News:Cheerios(R) Can Help Reduce Cholesterol 10 Percent in One Month 3Health News:Outgoing Nature Could Get You to 100 2Health News:Outgoing Nature Could Get You to 100 3Health News:The Tomato Products Wellness Council and SCAN Announce Winners for the Great Tomato Tip-Off Contest! 2Health News:The Tomato Products Wellness Council and SCAN Announce Winners for the Great Tomato Tip-Off Contest! 3Health News:New Human Study Reinforces Antioxidant Benefits of Tart Cherries 2Health News:New Human Study Reinforces Antioxidant Benefits of Tart Cherries 3Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 2Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 3Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 4
1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabric...
... A-scan Sonomed-315 is intended for visualization of ... of midline shifts in the brain, evaluation ... easy to use, the Sonomed-315 offers quick ... mode allows to identify the anatomic structures ...
... a scaleable device that works ... platelet plasma or buffy coat. ... coat must be prepared independently ... Starting volume and concentration factor ...
The Ultrafoam Collagen Sponge is indicated in all surgical procedures as an adjunct to hemostasis when control by ligature or conventional procedures are ineffective or impractical....
Medicine Products: